Demographics, Clinical Features, and Management Strategies Employed in Lung Transplant Patients Admitted With a Diagnosis of Gastroparesis to a Large Metropolitan Hospital (original ) (raw )A triple therapy regimen after failed Helicobacter pylori treatments
Salvatore Campo
Alimentary Pharmacology and Therapeutics, 2001
View PDFchevron_right
Long term follow-up after H.pylori eradication: Results of a prospective study
Antonio Ponzetto
Gastroenterology, 2000
View PDFchevron_right
Morbidity and mortality of serious gastrointestinal complications after lung transplantation
Félix Cambra
Journal of Cardiothoracic Surgery, 2019
View PDFchevron_right
Prevalence and Management of Gastrointestinal Complications in Lung Transplant Patients: MITOS Study Group
Carlos Jhair Perez Bravo
Transplant Proc, 2007
View PDFchevron_right
Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients
Nathalie Broutet , Herve Lamouliatte
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy
Hsiao-bai Yang
Digestive diseases and sciences, 2000
View PDFchevron_right
Concomitant, sequential, and hybrid therapy for H. pylori eradication: A pilot study
Valentina Ruggiero
Clinics and Research in Hepatology and Gastroenterology, 2013
View PDFchevron_right
How should Helicobacter pylori negative patients be managed?
Cesare Tosetti
Gut, 1999
View PDFchevron_right
Randomized study of two "rescue" therapies for helicobacter pylori-infected patients after failure of standard triple therapies
Virginia Festa
The American Journal of Gastroenterology, 2001
View PDFchevron_right
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy
Yoram Bujanover
Gut, 1995
View PDFchevron_right
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial
Iradj Maleki
Helicobacter, 2015
View PDFchevron_right
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection
Chiara Ricci
Clinical Gastroenterology and Hepatology, 2013
View PDFchevron_right
Update on Helicobacter pylori treatment
Adrienne Z Ables
American family physician, 2007
View PDFchevron_right
ERADICATION OF HELICOBACTER PYLORI INFECTION IN OUTPATIENT CARE Doctoral thesis (PhD)
György Miklós Buzás
2007
View PDFchevron_right
A Comparison between Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Eradication in Patients with Uremia: A Randomized Clinical Trial
Hafez Fakheri
Middle East Journal of Digestive Diseases, 2015
View PDFchevron_right
Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication: A Multicentre, Double-Blind, Randomised Clinical Trial
Arturo Fueyo
Clinical Drug Investigation, 2001
View PDFchevron_right
Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report
G. Tytgat
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Two new treatment regimens for Helicobacter pylori eradication: a randomised study
C. Panella , Enzo Ierardi
Digestive and Liver Disease, 2001
View PDFchevron_right
Tu1311 - Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Large, Prospective, Real Life Study
Antonio Tursi
Gastroenterology, 2018
View PDFchevron_right
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy
Virginia Festa
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection
debora formisano
World journal of gastroenterology : WJG, 2012
View PDFchevron_right
Helicobacter pylori eradication in renal transplant candidates
Vinicius Delfino
Brazilian Journal of Nephrology, 2022
View PDFchevron_right
Eradication of Helicobacter pylori by 7-Day Triple-Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double-Blind, Randomized Studies
Hala El-zimaity
Helicobacter, 2003
View PDFchevron_right
2-Week Triple Therapy for Helicobacter pylori Infection is Better Than 1-Week in Clinical Practice: a Large Prospective Single-Center Randomized Study
Federico Iacopini
Helicobacter, 2006
View PDFchevron_right
The influence of pretreatment on cure rates of Helicobacter pylori eradication
Wink De Boer
The Netherlands Journal of Medicine
View PDFchevron_right
Treatment for Helicobacter pylori infection, an overview
Eskandar Hajiani
2009
View PDFchevron_right
Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
James Brasic
Nutrients
View PDFchevron_right
A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
Iradj Maleki
Middle East journal of digestive diseases, 2016
View PDFchevron_right
Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
Enzo Ierardi
Journal of Medical Microbiology, 2014
View PDFchevron_right
Gastroparesis after Lung Transplantation: Prevalence, Reversibility and Relation with Outcome
Erik Verschuuren
Journal of Heart and Lung Transplantation, 2013
View PDFchevron_right
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice
Rita Angelini
Digestive and Liver Disease, 2010
View PDFchevron_right
Therapy for <i>H.</i> <i>pylori</i>: Current concepts
Chiara Ricci
Open Journal of Gastroenterology, 2013
View PDFchevron_right
Four-Day, Twice Daily, Quadruple Therapy with Amoxicillin, Clarithromycin, Tinidazole and Omeprazole to Cure Helicobacter pylori Infection: A Pilot Study
Neus Garcia
Helicobacter, 2000
View PDFchevron_right